Eisai currently works across Europe in the areas of Alzheimer’s disease, gastro-intestinal disorders, epilepsy, cervical dystonia, severe chronic pain and oncology.

Prialt®

Ziconotide
Click here for the Prialt Medicines Guide

Background

Prialt® (ziconotide) is a peptide which is the synthetic equivalent of a peptide found in a marine snail. It is used for the treatment of severe, chronic pain in adults.

Chronic Pain

Chronic pain is persistent pain where pain signals keep firing in the nervous system over a long period of time. Many chronic pain conditions affect older adults. Common severe, chronic pain complaints include failed back surgery syndrome, cancer pain, arthritis pain and neurogenic pain (pain resulting from damage to the peripheral nerves or to the central nervous system itself).

Clinical Action

Ziconotide suppresses pain by selectively blocking N-type calcium channels on nerves.

Further Information

The Summary of Product Characteristics and the Patient Information Leaflet (PIL), can be found at www.emc.medicines.org.uk

If you are not a healthcare professional and have any questions or concerns, please consult your healthcare professional directly

Adverse Events

All medicines may have side-effects. Please consult the patient information leaflet for a full list of side effects associated with the use of Prialt - see link above.

Understanding the future information for investors